I have just started thinking about this stock today so go easy on me if my questions have already been covered on this thread. Apologies in advance!
Chalkies article says:
Bladderchek, for example, aims to spot high levels of a protein called NMP22, which is released from cancer cells into the urine. Used alongside cytoscopy, Bladderchek provides up to 99 per cent sensitivity, its makers claim.
On it's own Bladderchek isn't very useful finding only 38% of cancer cases.
Cxbladder detects 62% of cancer cases. Better but still not enough to rely on.
So my question is what sensitivity do Cxbladder and cytoscopy provide?
Is it higher than "up to 99% sensitivity"?
If not (and this is key to the following question) why will doctors use it? Dollar savings won't be enough when lives/law suits are on the line.